On the basis of region, the global near infrared medical imaging market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global near infrared medical imaging market and is expected to retain its dominance over the forecast period, owing to large population suffering from breast cancer and other neurological diseases. According to the American Cancer Society, invasive breast cancer was diagnosed in around 231,840 patients in the U.S. in 2015. Furthermore, key players in the market are introducing novel products, which is expected to aid in growth of the market in the region.

For instance, in April 2017, Leica Microsystems introduced augmented reality near infrared fluorescence integrated imaging system GLOW800 at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting that facilitates full visual spectrum of white light into a single, real-time image. Asia Pacific is expected to witness a significant growth in the market, owing to increasing investments by international players by collaborating with regional players in the market. For instance, in June 2012, Infradex, Inc., a medical device company signed an exclusive agreement with Nipro Corporation for the distribution of TVC near infrared spectroscopy imaging system in Japan.

Competitive Landscape

Key players operating in the global near infrared medical imaging market include Bruker Corporation, Carl Zeiss Meditec AG, Shimadzu Corporation, PerkinElmer, Inc., MIZUHO Corporation, Karl Storz GmbH, and NOADAQ Technologies, Inc. among others. Market players are focused on providing technologically advanced products to sustain their position in the competitive market. For instance, in April 2018, Shimadzu Corporation introduced new LIGHTVISION near-infrared fluorescence imaging system for visualizing lymph nodes and blood vessels for the diagnosis and treatment of breast cancer.